PHP141 Effects of Changing Health Policy on Pharmacoeconomics and Health Outcome Studies in Turkey by Kockaya, G, Daylan Kockaya, P, Ergin Oguzhan, G

Get full text

PHS33 Cost Analysis of Dialysis Practice in Turkey by Tatar, M, Ergin oguzhan, G, Kockaya, G

Get full text

PRO48 COST OF HAEMATOPOIETIC STEM CELL TRANSPLANT IN TURKEY by Kockaya, G., Oguzhan Ergın, G., Çalışkan, Z.

Get full text

PNS159 PHARMACOECONOMICS AND HEALTH OUTCOME STUDIES IN TURKEY: ISPOR DATABASE SEARCH by Oguzhan Ergın, G., Kockaya, G., Ulger, F.M.

Get full text

PGI25 CLINIC AND ECONOMIC ANALYSIS FOR DIAGNISIS AND TREATMENT OF DIFFICULT BILE DUCT STONES WITH SINGEL OPERATOR CHOLANGIISCOPY IN TURKEY by Kockaya, G., Oguzhan Ergın, G., Şen, S.

Get full text

PBI42 ANALYSIS OF GENE AND CELL THERAPIES POLICIES IN EUROPEAN COUNTRIES by Oguzhan Ergın, G., Kockaya, G., Ulger, F.M.

Get full text

PRO49 ANNUAL COST OF TREATMENT OF SPINAL MUSCULAR ATROPHU PATIENTS IN TURKEY by Kockaya, G., Oguzhan Ergın, G., Çalışkan, Z.

Get full text

PMH67 ANALYSIS OF PSYCHOTROPIC MEDICATIONS PRESCRIPTIONS IN TURKEY by Adam, K., Kockaya, G., Oguzhan Ergın, G.

Get full text

PNS188 ANALYSIS OF MARKET ACCESS AGREEMENTS IN TURKEY by Kockaya, G., Okcun, S., Kurnaz, M., Oguzhan Ergın, G.

Get full text

PCV94 COST EFFECTIVENESS OF RIVAROXABAN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION PATIENTS FOR TTR AND CHADS2 SCORE IN LITHUANIA by Kockaya, G., Aidietiene, S., Oguzhan Ergın, G., Okcun, S., Kurnaz, M.

Get full text

PCN301 PATIENT ACCESS TO PERSONALIZED ONCOLOGY MEDICINES IN TURKEY by Oguzhan Ergın, G., Kockaya, G., Okcun, S., Kurnaz, M., Sar Gedik, C., Saylan, M.

Get full text

PRO75 PATIENT ACCESS TO ORPHAN MEDICINES IN TURKEY by Kockaya, G., Oguzhan Ergın, G., Kurnaz, M., Okcun, S., Talay, D., Sar Gedik, C., Saylan, M.

Get full text

PMS32 COST MINIMIZATION ANALYSIS OF ZENTIUS FOR THE TREATMENT OF VITAMIN D AND CALCIUM DEFICIENCY IN TURKEY by Çalışkan, Z., Kockaya, G., Kurtulus, H., İmer, B., Oguzhan Ergın, G.

Get full text

PMU52 - COST IN COMPLEX ABDOMINAL OPERATIONS IN PUBLIC HEALTH INSURANCE PERSPECTIVE FOR TURKEY by Kockaya, G, Oguzhan Ergın, G, Cavus, F, Sharaf, A, Akgul, T, Ozdemir, Z

Get full text

PCV61 COST EFFECTIVENESS OF RIVAROXABAN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION PATIENTS FOR TTR AND CHADS2 SCORE IN TURKEY by Oguzhan Ergın, G., Kockaya, G., Çalışkan, Z., Okcun, S., Kurnaz, M., Buyuktuna, N., Buyukisik, T., Saylan, M.

Get full text

PCV75 COST ANALYSIS OF COMPLICATIONS WITH CORONARY ARTERY DISEASE OR PERIPHERAL ARTERY DISEASE IN TURKEY by Kockaya, G., Oguzhan Ergın, G., Çalışkan, Z., Kurnaz, M., Okcun, S., Buyuktuna, N., Buyukisik, T., Saylan, M.

Get full text

PCV48 COST EFFECTIVENESS OF RIVAROXABAN IN CORONARY ARTERY DISEASE AND/OR PERIPHERAL ARTERY DISEASE FOR 5 DIFFEREN PATIENT SUB-GROUPS IN TURKEY by Kockaya, G., Oguzhan Ergın, G., Çalışkan, Z., Okcun, S., Kurnaz, M., Buyuktuna, N., Buyukisik, T., Saylan, M.

Get full text

PCV70 - EFFECT OF TIME IN THERAPEUTIC RANGE ON COST AND CLINICAL OUTCOMES OF ATRIAL FIBRILATION PATIENTS : A COST-CONSEQUENCES ANALYSIS OF RIVAROXABAN VS WARFARIN FOR TURKEY by Kockaya, G., Cavus, F., Ozin, B., Yilmaz, K.C., Ciftci, O., Oguzhan Ergın, G., Sharaf, A., Buyuktuna, N., Buyukisik, T., Saylan, M.

Get full text

PCV65 - EXPERT ANALYSIS ON COST ANALYSIS OF MANAGEMENT OF CARDIOVASCULAR DISEASE CO-MORBIDITIES by Kockaya, G., Cavus, F., Ozin, B., Yilmaz, K.C., Ciftci, O., Oguzhan Ergın, G., Sharaf, A., Buyuktuna, N., Buyukisik, T., Saylan, M.

Get full text

Hematologic Parameters and Angiographic Progression of Coronary Atherosclerosis by Kalay, Nihat, Dogdu, Orhan, Koc, Fatih, Yarlıoglues, Mikail, Ardic, Idris, Akpek, Mahmut, Cicek, Davran, Oguzhan, Abdurrahman, Ergin, Ali, Kaya, Mehmet G.

Get full text